Cardiovascular Medicine Book

Approach

Causes

Evaluation

Information Resources

Management

Miscellaneous

Endocrinology Chapter related topics

Examination Chapter related topics

Geriatric Medicine Chapter related topics

Neonatology Chapter related topics

Neurology Chapter related topics

Obstetrics Chapter related topics

Ophthalmology Chapter related topics

Pediatrics Chapter related topics

Pharmacology Chapter related topics

Prevention Chapter related topics

Pulmonology Chapter related topics

Sports Medicine Chapter related topics

http://www.fpnotebook.com/

Hypertension Risk StratificationAka: Hypertension Risk Group A, Hypertension Risk Group B, Hypertension Risk Group C

Advertisement

  1. See Also
    1. Hypertension
    2. Hypertension Evaluation
    3. Hypertension Management
  2. Indication
    1. JNC VII Guide for Hypertension Intervention
  3. Risk Group A: Low Cardiovascular Risk
    1. Criteria
      1. No Cardiovascular Risks (See Risk Group B)
      2. No Target organ damage or Cardiovascular Disease
    2. Prehypertension (120-139 / 80-89)
      1. Lifestyle Modification in Hypertension
    3. Stage 1 Hypertension (140-159 / 90-99)
      1. Lifestyle Modification in Hypertension
      2. Consider Antihypertensive after up to 6-12 months
        1. Hydrochlorothiazide first choice in most patients
    4. Stage 2 Hypertension or greater (>159/99)
      1. Lifestyle Modification in Hypertension
      2. Hypertension Combination Therapy
  4. Risk Group B: Moderate Cardiovascular Risk
    1. Criteria
      1. Tobacco Abuse
      2. Dyslipidemia
      3. Renal insufficiency
      4. Patient age over 60 years
      5. Male gender of postmenopausal women
      6. Cardiovascular Family History
      7. No Diabetes Mellitus
      8. No Target organ damage or Cardiovascular Disease
    2. Prehypertension (120-139 / 80-89)
      1. Lifestyle Modification in Hypertension
    3. Stage 1 Hypertension (140-159 / 90-99)
      1. Lifestyle Modification in Hypertension
      2. Antihypertensive (e.g. Hydrochlorothiazide)
    4. Stage 2 Hypertension or greater (>159/99)
      1. Lifestyle Modification in Hypertension
      2. Hypertension Combination Therapy
  5. Risk Group C: High Cardiovascular Risk
    1. Criteria
      1. Target organ damage or Cardiovascular Disease
        1. Left Ventricular Hypertrophy
        2. Angina or prior Myocardial Infarction
        3. Prior coronary revascularization
        4. Cerebrovascular Accident (Stroke or CVA)
        5. Transient Ischemic Attack (TIA)
        6. Nephropathy or Chronic Kidney Disease
        7. Peripheral Vascular Disease
        8. Retinopathy
      2. Cardiovascular Risks (See Risk Group B)
    2. Prehypertension (120-139 / 80-89) or greater
      1. Lifestyle Modification in Hypertension
      2. Antihypertensive
      3. Hypertension Combination Therapy if >20/10 over goal
  6. References
    1. (1997) Arch Intern Med 157:2413
    2. Chobanian (2003) JAMA 289:2560

Navigation Tree